InvestBio Portfolio Company The Vaccine Company LP Presents Phase I/II Trial Results of Vaccine for Leukemia at American Society of HematologyAnnual Meeting

NEW YORK--(BUSINESS WIRE)--Results from a clinical study using technology licensed by The Vaccine Company (TVC), an InvestBio, Inc. portfolio company, were presented at the 49th Annual Meeting of the American Society of Hematology.